Vistin Pharma ASA: Invitation to Q1 2025 conference call
Werte in diesem Artikel
Oslo, Norway, 15 April 2025
Vistin Pharma ASA (VISTN) will release its first quarter results on Friday 25th of April 2025. Vistin Pharma will host a conference call for all shareholders and interested parties at the same day at 08:30 CET. There will be a Q&A session following the management discussion.
The conference call will be held in English.
The first quarter conference call will be available via web and audio through the following access points:
Webcast: https://edge.media-server.com/mmc/p/9g56ohth
Telephone conference (online registration):
https://register-conf.media-server.com/register/BI532205913f1d42059d747081a631bec9
*****
For further information, please contact:
Alexander Karlsen
CFO
+47 97053621
alexander.karlsen@vistin.com
About Vistin Pharma | www.vistin.com
Vistin Pharma is a Norwegian pharmaceutical company producing Metformin Hydrochloride (API). The Metformin is also available as Direct Compressible lubricated granules. As a solely dedicated European Metformin producer, Vistin Pharma is a well-positioned supplier to leading pharmaceutical companies. Vistin Pharma is headquartered in Oslo, Norway, and has highly qualified employees and a dedicated manufacturing facility in Kragerø.
Ausgewählte Hebelprodukte auf Vistin Pharma ASA
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Vistin Pharma ASA
Der Hebel muss zwischen 2 und 20 liegen
| Name | Hebel | KO | Emittent |
|---|
| Name | Hebel | KO | Emittent |
|---|
Nachrichten zu Vistin Pharma ASA
Analysen zu Vistin Pharma ASA
Keine Analysen gefunden.